D-EYE, Srl
Funding allows for expansion of low-cost alternative to traditional ophthalmoscopy examination and telehealth solution
D-EYE, Srl, the first to design an affordable smartphone-based retinal imaging system – today announced that it has received seed funding from Innogest, Invitalia Ventures, Giuseppe e Annamaria Cottino Foundation, and Si14, Spa, to advance the company’s mobile device hardware and proprietary application and cloud software. The D-EYE system works in harmony with smartphones, allowing medical professionals to screen patients for eye health issues when examining the retina. Images taken can be stored, transmitted and shared via the HIPAA compliant D-EYE ImageVault™.
“We are very pleased with the investment partnership that the leading venture capital firm in Italy, Innogest, has formed, allowing us to expand the use of our hardware product and to introduce our encrypted mobile application platform and cloud based patient record system”, said Richard Sill, CEO of D-EYE, Srl. “Our mission is to help the 300+ million people around the world who suffer from vision loss receive earlier intervention, especially those in rural or remote areas.
“Digital health solutions can contribute significantly to the prevention and monitoring of chronic diseases which will have a huge impact on quality of life and overall healthcare costs”, said Claudio Rumazza, Partner at Innogest. “As an example, D-EYE is well positioned to foster a paradigm shift in eye care, thanks to its complete service offering and flexibility of the system.”
The D-EYE retinal imaging system is the first product of its kind to adapt to multiple smartphones (today: Apple iPhone5 and 6 – Samsung s4 and s5), record videos or images of the posterior of the eye, save and transmit for further assessment.
Now available and shipping to customers for $399, the patent pending D-EYE Portable Retinal Imaging System is the result of ground-breaking work done by Italian Ophthalmologist Dr. Andrea Russo, in collaboration with the University of Brescia. Dr. Russo invented D-EYE to improve access to vital retinal screenings for people in need.
The company received US FDA Class 510(K) exempt listing number D231842 on Dec. 19, 2014, and CE Class 1 device registration number 1243284 on Dec. 20, 2014. In conjunction with the announcement of these registrations, D-EYE is working with in-country partner distributors and resellers from around the world. https://www.d-eyecare.com/en_IT/distributors
Additionally, the D-EYE Portable Retinal Imaging System is an effective tool for veterinarians to use to examine dogs, cats and other small animals to detect glaucoma and other sight-threatening conditions.
For more information about the revolutionary D-EYE Portable Retinal Imaging System, please visit www.deyecare.com